AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27955682
Drug: Telehealthcare (Telekit)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telehealthcare (Telekit) solution
Trial: 15611784
Drug: Capsaicin capsules
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin capsules (0.9 g red pepper; 0.25% capsaicin; 80,000 Scoville Thermal Units)
Trial: 15611784
Drug: Capsaicin in
RxNorm normalized name: capsaicin in castor oil 0.035 % TOPICAL LIQUID (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin in tomato juice (0.9 g red pepper; 0.25% capsaicin; 80,000 Scoville Thermal Units)
Trial: 15611784
Drug: Placebo (offered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (offered in tomato juice or capsules)
Trial: 15611784
Drug: Capsaicin conditions
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin conditions (both oral and gastrointestinal)
Trial: 10417874
Drug: Ajoene (0.6%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ajoene (0.6%, gel)
Trial: 10417874
Drug: Terbinafine (1%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine (1%, cream)
Trial: 8524604
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation of the tibialis anterior muscle for 4 weeks at twice the motor threshold
Trial: 8524604
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation for 4 weeks at twice motor threshold
Trial: 2196942
Drug: Elastosis and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elastosis and presence of estrogen and progesterone receptors
Trial: 25948515
Drug: Focused extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Focused extracorporeal shock wave therapy (0.25 mJ/mm(2)) with three sessions of 2000 impulses in weekly intervals
Trial: 25948515
Drug: Focused extracorporeal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Focused extracorporeal shock wave therapy (0.25 mJ/mm(2))
Trial: 23624419
Drug: Vildagliptin 50mg
RxNorm normalized name: vildagliptin
DrugBank: Vildagliptin (DB04876)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Vildagliptin 50mg twice a day in addition to metformin
Trial: 23624419
Drug: Vildagliptin+metformin
RxNorm normalized name: vildagliptin
DrugBank: Vildagliptin (DB04876)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Vildagliptin+metformin
Trial: 23624419
Drug: Placebo+metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo+metformin
Trial: 21784309
Drug: Calcium tablet
RxNorm normalized name: Vinate Calcium Tablet
DrugBank: Calcium sulfate (DB15533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium tablet (600 mg once daily as CaCO3)
Trial: 21784309
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet once daily
Trial: 18795291
Drug: Erlotinib 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 50 mg daily with standard-dose cetuximab
Trial: 18795291
Drug: Bevacizumab 10
RxNorm normalized name: bevacizumab 100 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab 10 mg/kg biweekly
Trial: 16915874
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for 12 weeks
Trial: 15553594
Drug: n‐3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 PUFA 6.6 g
Trial: 15553594
Drug: n‐3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 PUFA 2.0 g
Trial: 9062368
Drug: oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral acyclovir 400 mg PO twice a day
Trial: 29071464
Drug: Glucagon infusion
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Glucagon infusion (elevated blood glucose levels)
Trial: 17938811
Drug: Lower tertile
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower tertile platelet count (<198 x 10(9)/L)
Trial: 17938811
Drug: Middle tertile
RxNorm normalized name: wheat middlings extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Middle tertile platelet count (198-244 x 10(9)/L)
Trial: 17938811
Drug: Upper tertile
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Upper tertile platelet count (>244 x 10(9)/L)
Trial: 11911935
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g amino-acid drink without tryptophan (depletion condition)
Trial: 11911935
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g amino-acid drink with tryptophan (placebo condition)
Trial: 9717598
Drug: Diltiazem (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (0.2 mg.kg‐1)
Trial: 334028
Drug: Oestriol succinate
RxNorm normalized name: Oestriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestriol succinate therapy (2 mg/day)
Trial: 334028
Drug: Oestriol succinate
RxNorm normalized name: Oestriol
DrugBank: Estriol (DB04573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestriol succinate therapy
Trial: 28408545
Drug: Multifaceted service
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multifaceted service involving a pharmacist integrated into a medical centre to assist patients after hospitalisation; includes follow-up and medication reconciliation.
Trial: 18410408
Drug: Oral acitretin
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acitretin 0.4 mg kg(‐1) daily
Trial: 18410408
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg once weekly plus acitretin 0.4 mg kg(‐1) daily
Trial: 16338779
Drug: Butoconazole nitrate
RxNorm normalized name: Butoconazole Nitrate
DrugBank: Butoconazole (DB00639)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Butoconazole nitrate 2% Site Release vaginal cream
Trial: 16338779
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg tablets
Trial: 12017904
Drug: Tramadol 50
RxNorm normalized name: traMADol 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 50 mg, as a single dose, administered either 2 hours prior or immediately before the surgical procedure
Trial: 10450625
Drug: Fluoxetine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (30 or 60 mg daily)
Trial: 25951410
Drug: Eating marshmallows
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eating marshmallows (3 marshmallows three times daily)
Trial: 23157581
Drug: Topiramate (3-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (3-25 mg/kg/day)
Trial: 22195380
Drug: Atraumatic Restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic Restorative Treatment (ART) restorations with conditioners (GC Dentine Conditioner)
Trial: 22195380
Drug: Atraumatic Restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic Restorative Treatment (ART) restorations without conditioners
Trial: 18982338
Drug: NSAID (diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID (diclofenac 3 x 50 mg oral)
Trial: 15991780
Drug: Nurse-delivered intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-delivered intervention including tailored information, assessment of withdrawal, offer of nicotine replacement therapy, booklets, and a discharge letter.
Trial: 12630068
Drug: Complete testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Complete testosterone suppression therapy
Trial: 9527278
Drug: Erythropoietin (EPO)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (EPO) administered intravenously after dialysis
Trial: 9527278
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (placebo) administered intravenously after dialysis
Trial: 7885125
Drug: Cotrimoxazole (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cotrimoxazole (160 mg trimethoprim, 800 mg sulphamethoxazole)
Trial: 2221512
Drug: IV metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV metoclopramide 10 mg
Trial: 390339
Drug: Timolol administered
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol administered once a day
Trial: 390339
Drug: Timolol administered
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol administered twice a day
Trial: 390339
Drug: Timolol combined
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol combined with a diuretic
Trial: 19232615
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (n=121)
Trial: 15239792
Drug: 1.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/day molecular iodine for 6 months
Trial: 15239792
Drug: 3.0 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 mg/day molecular iodine for 6 months
Trial: 15239792
Drug: 6.0 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.0 mg/day molecular iodine for 6 months
Trial: 3285838
Drug: bromocriptine (2.5-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromocriptine (2.5-30 mg/d)
Trial: 24768981
Drug: Intravaginal misoprostol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal misoprostol, 400 μg, with 100 mL of 5% intravenous glucose (misoprostol arm)
Trial: 24768981
Drug: Intravenous ketoprofen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketoprofen, 50 mg/mL, in 100 mL 5% glucose with intravaginal placebo (ketoprofen arm)
Trial: 24768981
Drug: Vaginal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal placebo tablets, 100 mL 5% intravenous glucose (placebo arm)
Trial: 21073062
Drug: 2PE preserved
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2PE preserved hepatitis B vaccine kept on the shelf <12 months (2PE New group)
Trial: 21073062
Drug: 2PE preserved
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2PE preserved hepatitis B vaccine kept on the shelf >18 months (2PE Old group)
Trial: 21073062
Drug: Thiomersal preserved
RxNorm normalized name: thiomersal
DrugBank: Thimerosal (DB11590)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiomersal preserved hepatitis B vaccine [HBV(Thio) group]
Trial: 21073062
Drug: 2PE preserved
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2PE preserved hepatitis B vaccine
Trial: 17166386
Drug: Injection Yiyoutasai
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection Yiyoutasai (75 mg/m², every 3 weeks)
Trial: 17166386
Drug: Injection Aisu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection Aisu (75 mg/m², every 3 weeks)
Trial: 2203467
Drug: Antibiotic plus
RxNorm normalized name: Triple Antibiotic Plus
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic plus steroid
Trial: 870388
Drug: Infusions of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusions of dextran
Trial: 870388
Drug: Postoperative oral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative oral anticoagulation with cumarins
Trial: 870388
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug prophylaxis)
Trial: 27116918
Drug: Varenicline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (1 mg twice a day)
Trial: 27116918
Drug: Bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion (150 mg twice a day)
Trial: 27116918
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (21 mg per day with taper)
Trial: 24725169
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg tamsulosin (two tablets of 0.2 mg once daily)
Trial: 24725169
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg tamsulosin (one tablet of 0.2 mg and one tablet of placebo once daily)
Trial: 22858560
Drug: Individualised sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised sensitivity elimination dose
Trial: 22858560
Drug: Standardised 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardised 15 min dose
Trial: 19328636
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg St John's wort (SJW) active
Trial: 17127698
Drug: Short induction
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short induction therapy with anti-thymoglobulin (ATG) and steroids for 4 days, followed by CellCept and tacrolimus
Trial: 15894902
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg for 4 weeks followed by 10 mg for 4 weeks, n = 22)
Trial: 15894902
Drug: Telmisartan (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (80 mg for 8 weeks, n = 18)
Trial: 15894902
Drug: Ramipril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (2.5 mg for 1 week, 5.0 mg for 3 weeks and 10 mg for 4 weeks, n = 17)
Trial: 10538640
Drug: Higher age,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher age, breast-feeding, and knowledge of the recommendation to eat five or more servings of fruits and vegetables daily.
Trial: 8878716
Drug: medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: medroxyprogesterone acetate (MPA) 5 mg b.i.d.
Trial: 8878716
Drug: dydrogesterone (DG)
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: dydrogesterone (DG) 10 mg b.i.d.
Trial: 1725022
Drug: Ramipril, 10
RxNorm normalized name: Ramipril, 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril, 10 mg once daily for 4 weeks
Trial: 31113725
Drug: Sitafloxacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitafloxacin (100 mg/day for 3–10 days)
Trial: 31113725
Drug: Garenoxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garenoxacin (400 mg/day for 3–10 days)
Trial: 24844530
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy (iCBT) program in Manga format, delivered over six weeks with one lesson per week
Trial: 20334707
Drug: 2.2 g
RxNorm normalized name: Vaporizer Safeguard 2.2 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.2 g of marine n-3 PUFA daily for 12 weeks
Trial: 20334707
Drug: Control oil
RxNorm normalized name: SALICYLIC ACID 29.2 mg TOPICAL LIQUID [Acne Control oil-free Cleansing]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control oil daily for 12 weeks
Trial: 18689157
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care for hemophilia with inhibitors as per regional consensus and clinical guidelines.
Trial: 15639064
Drug: Drospirenone 3
RxNorm normalized name: drospirenone 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone 3 mg / Ethinyl Estradiol 30 microg (DRSP/EE)
Trial: 10233563
Drug: Oral desmopressin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral desmopressin
Trial: 8942381
Drug: Hyaluronidase (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronidase (25 IU/ml of mixture)
Trial: 31336633
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice (150 mL, 10.5 mmol nitrate)
Trial: 31336633
Drug: Placebo (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (150 mL, 1 mmol nitrate)
Trial: 23171659
Drug: Online disease
RxNorm normalized name: LYME DISEASE VACCINE
DrugBank: Lyme disease vaccine (recombinant OspA) (DB00045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online disease management intervention (n=193) including wirelessly uploaded glucometer readings, patient-specific reports, nutrition and exercise logs, insulin records, online messaging, nurse and dietitian support, and educational content.
Trial: 20214224
Drug: BCAA granules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA granules (14.22 g/day)
Trial: 9302131
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of 20 microg alprostadil alfadex (prostaglandin E1)
Trial: 9302131
Drug: 30-minute intravenous
RxNorm normalized name: TAGETES MINUTA FLOWER OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-minute intravenous infusion of 20 microg alprostadil alfadex (prostaglandin E1)
Trial: 8193494
Drug: Regular, aluminium‐adsorbed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular, aluminium‐adsorbed diphtheria‐tetanus vaccine
Trial: 8193494
Drug: Non‐adsorbed diphtheria‐tetanus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non‐adsorbed diphtheria‐tetanus vaccine
Trial: 3332574
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS (30 mg, 60 mg, or 90 mg once daily)
Trial: 3332574
Drug: Long-acting propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting propranolol (80 mg, 160 mg, or 240 mg once daily)
Trial: 27374465
Drug: Rituximab maintenance
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab maintenance therapy (375 mg/m² every 3 months for 2 years)
Trial: 19338146
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection (SFI) pre-treated group
Trial: 19338146
Drug: Shenfu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu Injection (SFI) post-treated group
Trial: 16145898
Drug: Astragali injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astragali injection
Trial: 3015809
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (50 g) given within 5 min of amitriptyline (75 mg) dose
Trial: 3015809
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (50 g followed by 12.5 g at 6-h intervals)
Trial: 2142700
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg dexamethasone
Trial: 21077943
Drug: Orlistat plus
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat plus L‐carnitine
Trial: 16963828
Drug: Subanesthetic ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subanesthetic ketamine infusion (0.5 mg/kg/h)
Trial: 9589227
Drug: Metformin 1
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1 g b.i.d. for 12 weeks
Trial: 9589227
Drug: Metformin at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin at baseline dosage (1-2.5 g) for 12 weeks
Trial: 3019375
Drug: Cilazapril 20
RxNorm normalized name: cilazapril
DrugBank: Cilazapril (DB01340)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilazapril 20 mg
Trial: 780059
Drug: Indoramin (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin (125 mg to 200 mg daily)
Trial: 28449972
Drug: Paracetamol (prophylactic)
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol (prophylactic)
Trial: 28449972
Drug: Paracetamol (therapeutic)
RxNorm normalized name: Moisturel Therapeutic
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol (therapeutic)
Trial: 29690924
Drug: No paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No paracetamol
Trial: 18501431
Drug: Ampicillin/sulbactam (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin/sulbactam (9 g every 8h)
Trial: 11099714
Drug: Piracetam 1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam 1600 mg t.i.d.
Trial: 11099714
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 200 mg t.i.d.
Trial: 15943850
Drug: lansoprazole 15
RxNorm normalized name: lansoprazole 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole 15 mg daily
Trial: 9663835
Drug: lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole 30 mg daily
Trial: 9663835
Drug: lansoprazole (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole (both doses)